News

Apr. 28, 2025Press Release

Sysmex Group’s New Manufacturing Base in India Begins Full-Scale Operations and Launches “Make in India” Products

Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announces today that its new manufacturing base in India, with production capabilities for both diagnostic reagents and instruments as the first of its kind for the Group, began full-scale operations in April 2025, and that the company has commenced manufacturing the XQ™-Series Automated Hematology Analyzer, (“XQ-320”) in the Indian market in response to the “Make in India” policy.

India is promoting the “Make in India” policy to foster economic growth, job creation, infrastructure, and technological innovation, and is implementing this policy into public procurement to favor domestically manufactured products. In response to this policy, Sysmex has achieved mass production of the XQ-320 at its new local manufacturing base, meeting the participation requirements for public procurement (local production and incorporation of local materials).

The XQ-320 is a compact and high-performance 3-part WBC differential model, specifically designed for small and medium-sized medical institutions that are often the focus of public procurement. Through various initiatives, including the selection of local material suppliers that meet Sysmex's quality standards and the training of local staff, we have established a mass production system for Indian-made products that assures Sysmex quality. With an eye on future demand for upgrading to 5-part WBC differential models, we aim to expand the market share of 3-part WBC differential models.

The new manufacturing base boasts the largest total floor area of all the Sysmex Group’s manufacturing bases outside Japan and produces both diagnostic reagents and instruments. It has become the Group’s second largest overseas instrument production base after the one in China, and the production capacity for diagnostic reagents has increased approximately four-fold compared to the existing local factory. Additionally, the new base is equipped with a zero liquid discharge system*, ensuring thorough environmental consideration.

These enhancements will strengthen the stable supply of products to the Indian market, improve customer satisfaction, and aim to accelerate business expansion.

Sysmex will continue to shape the advancement of healthcare in the Indian market and pursue initiatives to achieve sustainable growth. Going forward, Sysmex will continue to rapidly advance the establishment of manufacturing structures to ensure the stable delivery of products to customers around the world.

Overview of New Manufacturing Base in India

	Location:	Sanand II Industrial Estate, Gujarat, India
	Site area:	18,100㎡
	Floor space:	10,600㎡
	Investment:	Approx. 3 billion JPY
	Products manufactured:	Diagnostic reagents, instruments (manufacturing is to start with some models of hematology analyzers, to be expanded sequentially)

Product Overview

	Product name:	XQ™-Series Automated Hematology Analyzer
	Model name:	XQ-320
	Target market:	India

References

	April 17, 2023 news release: “Sysmex to Establish New Manufacturing Base in India - Creating a Manufacturing Structure in India to Support Sustainable Growth -” https://www.sysmex.co.jp/en/news/2023/230417.html

	August 1, 2024 news release: “Sysmex Group’s Largest Manufacturing Base Completed in India” https://www.sysmex.co.jp/en/news/2024/240801.html

Terminology

*	Zero liquid discharge system:
	A system that purifies and reuses wastewater from factories using multiple treatment methods, eliminating the discharge of wastewater outside the factory premises.

About Sysmex Corporation

Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide. Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalized medicine and novel treatments, under its long-term vision of "Together for a better healthcare journey." Through its unique technology, solutions, and co-creation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives.
For more information about Sysmex, please visit www.sysmex.co.jp/en/.

FOLLOW US　

The purpose of this news release is to communicate our business activities to our stakeholders. It may or may not include information about Sysmex's products or their research and development, but this is not intended for promotion, advertising or medical advice. The information contained in this news release is current as of the date of the announcement but may be subject to change without prior notice.

Back to "News"